All News
Quadria Group appoints Rahul Agarwal as Partner at HealthQuad
Quadria Group intends to announce a few more senior appointments to strengthen the investment and the operating capability at HealthQuad
Read MoreC.D.C. Vaccine Meeting: What to Watch For
Hints of a more skeptical approach to immunizations have already surfaced.
Read MoreKennedy’s Handpicked Vaccine Advisers Are Set to Meet for the First Time
The panelists will review measles vaccine recommendations and discuss a preservative that the health secretary has falsely claimed causes autism.
Read MorePromise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Read MoreThe Evolution of Trump’s Views on Foreign Aid
The administration has gutted agencies like U.S.A.I.D., and President Trump has denigrated their work as wasteful and rife with fraud.
Read MoreCalifornia’s Much-Touted IVF Law May Be Delayed Until 2026, Leaving Many in the Lurch
California lawmakers are poised to approve a six-month delay in implementing the state’s in vitro fertilization law, pushing its start to January 2026.
Read MoreWhat RFK Jr. Isn’t Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
Read MoreOpinion: What the Supreme Court doesn’t understand about medical care for trans youth
“As a pediatrician, I never imagined having lawmakers decide which children's suffering deserves treatment.
Read MoreWhy the company behind a controversial medical device just pivoted — to bitcoin
This week’s episode of a new video series from STAT delves into Semler Scientific's pivot from artery disease screening to bitcoin speculation. Our reporters explain the unusual move.
Read MoreSTAT+: Kennedy paves way for flood of wellness companies in white coats
With health secretary Robert F. Kennedy Jr.'s explicit and implicit encouragement, medical entrepreneurs are offering pricey new products, including some unproven to help.
Read More